Altimmune Inc
SWB:3G0
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
A
|
Altimmune Inc
SWB:3G0
|
US |
|
C
|
CapitaLand Ascendas REIT
OTC:ACDSF
|
SG |
|
Sixt SE
XETRA:SIX2
|
DE |
|
F
|
Fortive Corp
SWB:F03
|
US |
|
Boss Energy Ltd
ASX:BOE
|
AU |
|
SEB SA
PAR:SK
|
FR |
|
Kanzhun Ltd
NASDAQ:BZ
|
CN |
|
3
|
3M Co
XETRA:MMM
|
US |
|
V
|
Volatus Aerospace Inc
NEO:FLT
|
CA |
|
3i Group PLC
LSE:III
|
UK |
|
M
|
Merck KGaA
F:MRK
|
DE |
|
T
|
Task Group Holdings Ltd
ASX:TSK
|
NZ |
Intrinsic Value
Is 3G0 undervalued or overvalued?
See the intrinsic value estimate for
Altimmune Inc and find out whether today’s valuation is cheap or expensive by its own historical standards.
Do our valuations actually work? See backtest results .
Fundamental Analysis
What Altimmune Does
Altimmune is a clinical-stage biotechnology company that develops drugs for obesity, liver disease, and other serious conditions. It does not sell a finished medicine today; instead, it designs and tests experimental treatments in clinical trials, with a focus on peptide-based drugs and vaccine candidates.
- Headquarters
- United States of America US
- Employees
- 57
- IPO date
- Oct 6, 2005
Revenue & Expenses Breakdown
Altimmune Inc
Earnings Waterfall
Altimmune Inc
The intrinsic value for
Altimmune Inc (3G0) under the Base Case is hidden EUR.
Compared with the current market price of 2.545 EUR, the stock appears hidden.